• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

路易体痴呆:一项国际多中心研究的结果

Dementia with lewy bodies: findings from an international multicentre study.

作者信息

Del Ser T, McKeith I, Anand R, Cicin-Sain A, Ferrara R, Spiegel R

机构信息

Hospital Severo Ochoa, Madrid, Spain.

出版信息

Int J Geriatr Psychiatry. 2000 Nov;15(11):1034-45. doi: 10.1002/1099-1166(200011)15:11<1034::aid-gps231>3.0.co;2-5.

DOI:10.1002/1099-1166(200011)15:11<1034::aid-gps231>3.0.co;2-5
PMID:11113984
Abstract

OBJECTIVES

To describe the baseline demographic, neuropsychiatric and neurological data of a large selected clinical sample of patients with dementia with Lewy Bodies (DLB) from an international multicentre trial with rivastigmine. To examine the usefulness of the Consensus Criteria for the diagnosis of DLB in different countries.

METHODS

Seventeen centres from Spain, the UK and Italy recruited patients diagnosed clinically as probable DLB according to recent Consensus Criteria (McKeith et al., 1996). A standard clinical protocol including inclusion/exclusion criteria, collection of demographic and medical data, cognitive (Mini Mental State Examination: MMSE), motor (Unified Parkinson's Disease Rating Scale: UPDRS) and neuropsychiatric (Neuropsychiatric Inventory: NPI) examinations, was applied after obtaining informed consent. Data were summarised and compared across countries with uni- and multivariate analyses.

RESULTS

One hundred and twenty patients were recruited: 56.7% males, mean (SD) age 73.9 (6.4) years, range 57 - 87 years. Sixty percent fulfilled all three core diagnostic features of DLB, and 40% only two ('parkinsonism' 92.4%, 'cognitive fluctuations' 89.1%, 'visual hallucinations' 77.3%). 'Systematised delusions' (46%) and 'repeated falls' (42%) were the most frequent supportive diagnostic features. There were no differences across countries in demographic, diagnostic or clinical features. Patients showed a wide range of psychopathology which was weakly correlated with cognitive impairment. Some mild extrapyramidal signs (EPS) were observed in most patients.

CONCLUSIONS

The Consensus Criteria for DLB can be consistently applied across many different sites for multicentre studies. 'Parkinsonism' and 'cognitive fluctuations' as core features and 'systematised delusions' and 'repeated falls' as supportive features are the most frequent diagnostic clues. Neuropsychiatric disturbances, in particular apathy, delusions, hallucinations and anxiety, and mild symmetric EPS are frequent in DLB and are only related weakly to cognitive impairment.

摘要

目的

描述来自一项关于卡巴拉汀的国际多中心试验中,大量经过挑选的路易体痴呆(DLB)患者临床样本的基线人口统计学、神经精神和神经学数据。研究不同国家中DLB诊断共识标准的实用性。

方法

来自西班牙、英国和意大利的17个中心招募了根据最新共识标准(McKeith等人,1996年)临床诊断为可能患有DLB的患者。在获得知情同意后,应用了一个标准临床方案,包括纳入/排除标准、人口统计学和医学数据收集、认知(简易精神状态检查表:MMSE)、运动(统一帕金森病评定量表:UPDRS)和神经精神(神经精神科问卷:NPI)检查。通过单变量和多变量分析对各国数据进行汇总和比较。

结果

招募了120名患者:男性占56.7%,平均(标准差)年龄73.9(6.4)岁,年龄范围为57 - 87岁。60%的患者符合DLB的所有三个核心诊断特征,40%的患者仅符合两个特征(“帕金森综合征”92.4%,“认知波动”89.1%,“视幻觉”77.3%)。“系统性妄想”(46%)和“反复跌倒”(42%)是最常见的支持性诊断特征。各国在人口统计学、诊断或临床特征方面没有差异。患者表现出广泛的精神病理学症状,且与认知障碍呈弱相关。大多数患者观察到一些轻度锥体外系体征(EPS)。

结论

DLB的共识标准可在许多不同地点一致地应用于多中心研究。“帕金森综合征”和“认知波动”作为核心特征,“系统性妄想”和“反复跌倒”作为支持性特征是最常见的诊断线索。神经精神障碍,特别是淡漠、妄想、幻觉和焦虑,以及轻度对称性EPS在DLB中很常见,且仅与认知障碍呈弱相关。

相似文献

1
Dementia with lewy bodies: findings from an international multicentre study.路易体痴呆:一项国际多中心研究的结果
Int J Geriatr Psychiatry. 2000 Nov;15(11):1034-45. doi: 10.1002/1099-1166(200011)15:11<1034::aid-gps231>3.0.co;2-5.
2
Cholinesterase inhibitors for dementia with Lewy bodies.用于路易体痴呆的胆碱酯酶抑制剂。
Cochrane Database Syst Rev. 2003;2003(3):CD003672. doi: 10.1002/14651858.CD003672.
3
Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.用于路易体痴呆、帕金森病痴呆及帕金森病认知障碍的胆碱酯酶抑制剂
Cochrane Database Syst Rev. 2012 Mar 14;2012(3):CD006504. doi: 10.1002/14651858.CD006504.pub2.
4
Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study.卡巴拉汀治疗路易体痴呆的疗效:一项随机、双盲、安慰剂对照的国际研究。
Lancet. 2000 Dec 16;356(9247):2031-6. doi: 10.1016/S0140-6736(00)03399-7.
5
Long-Term use of rivastigmine in patients with dementia with Lewy bodies: an open-label trial.长期使用卡巴拉汀治疗路易体痴呆患者:一项开放标签试验。
Int Psychogeriatr. 2001 Jun;13(2):199-205. doi: 10.1017/s104161020100758x.
6
Rivastigmine in the treatment of dementia with Lewy bodies: preliminary findings from an open trial.卡巴拉汀治疗路易体痴呆:一项开放试验的初步结果。
Int J Geriatr Psychiatry. 2000 May;15(5):387-92. doi: 10.1002/(sici)1099-1166(200005)15:5<387::aid-gps131>3.0.co;2-9.
7
Dementia with Lewy bodies treated with rivastigmine: effects on cognition, neuropsychiatric symptoms, and sleep.用卡巴拉汀治疗路易体痴呆:对认知、神经精神症状及睡眠的影响
Int Psychogeriatr. 2001 Sep;13(3):277-88. doi: 10.1017/s1041610201007670.
8
Comparisons of clinical symptoms in biomarker-confirmed Alzheimer's disease, dementia with Lewy bodies, and frontotemporal dementia patients in a local memory clinic.当地记忆诊所中生物标志物确诊的阿尔茨海默病、路易体痴呆和额颞叶痴呆患者临床症状的比较。
Psychogeriatrics. 2015 Dec;15(4):235-41. doi: 10.1111/psyg.12103. Epub 2014 Dec 23.
9
Cognitive and psychopathologic response to rivastigmine in dementia with Lewy bodies compared to Alzheimer's disease: a case control study.与阿尔茨海默病相比,路易体痴呆患者对卡巴拉汀的认知和精神病理反应:一项病例对照研究。
Am J Alzheimers Dis Other Demen. 2007 Feb-Mar;22(1):42-7. doi: 10.1177/1533317506297517.
10
Pharmacologic treatment expectations in the management of dementia with Lewy bodies.路易体痴呆管理中的药物治疗期望
Dement Geriatr Cogn Disord. 2004;17 Suppl 1:32-9. doi: 10.1159/000074680.

引用本文的文献

1
Psychotic Disorders in Epilepsy: Do They Differ from Primary Psychosis?癫痫相关精神病性障碍:与原发性精神病有何不同?
Curr Top Behav Neurosci. 2022;55:183-208. doi: 10.1007/7854_2021_234.
2
Progression of Clinical Features in Lewy Body Dementia Can Be Detected Over 6 Months.路易体痴呆的临床特征可在 6 个月内被检测到进展。
Neurology. 2021 Sep 7;97(10):e1031-e1040. doi: 10.1212/WNL.0000000000012450. Epub 2021 Aug 17.
3
Mini-Cog for the detection of dementia within a secondary care setting.简易认知评估量表在二级医疗环境下用于痴呆的检测。
Cochrane Database Syst Rev. 2021 Jul 14;7(7):CD011414. doi: 10.1002/14651858.CD011414.pub3.
4
The Role of Neuropsychiatric Symptoms in Research Diagnostic Criteria for Neurodegenerative Diseases.神经精神症状在神经退行性疾病研究诊断标准中的作用。
Am J Geriatr Psychiatry. 2021 Apr;29(4):375-383. doi: 10.1016/j.jagp.2020.07.011. Epub 2020 Jul 27.
5
Cognitive Impairment Evaluation and Management.认知障碍评估与管理。
Med Clin North Am. 2020 Sep;104(5):807-825. doi: 10.1016/j.mcna.2020.06.007.
6
Mini-Cog for the diagnosis of Alzheimer's disease dementia and other dementias within a secondary care setting.用于在二级医疗环境中诊断阿尔茨海默病性痴呆及其他痴呆症的简易认知评估量表。
Cochrane Database Syst Rev. 2019 Sep 14;9(9):CD011414. doi: 10.1002/14651858.CD011414.pub2.
7
Association of visual hallucinations with very mild degenerative dementia due to dementia with Lewy bodies.与路易体痴呆引起的极轻度退行性痴呆相关的视幻觉。
PLoS One. 2018 Oct 15;13(10):e0205909. doi: 10.1371/journal.pone.0205909. eCollection 2018.
8
Gender and Pathology-Specific Effect of Apolipoprotein E Genotype on Psychosis in Alzheimer's Disease.载脂蛋白E基因分型对阿尔茨海默病性精神病的性别及病理特异性影响
Curr Alzheimer Res. 2017;14(8):834-840. doi: 10.2174/1567205014666170220150021.
9
Relationship between Dementia Severity and Behavioral and Psychological Symptoms of Dementia in Dementia with Lewy Bodies and Alzheimer's Disease Patients.路易体痴呆和阿尔茨海默病患者的痴呆严重程度与痴呆的行为和心理症状之间的关系
Dement Geriatr Cogn Dis Extra. 2015 Jun 6;5(2):244-52. doi: 10.1159/000381800. eCollection 2015 May-Aug.
10
Positive FP-CIT SPECT (DaTSCAN) in Clinical Alzheimer's Disease - An Unexpected Finding?临床阿尔茨海默病中氟哌啶醇-铟[¹²³I] SPECT(DaTSCAN)阳性——一个意外发现?
Dement Geriatr Cogn Dis Extra. 2011 Jan;1(1):283-91. doi: 10.1159/000330470. Epub 2011 Sep 21.